Our parent company, Mitsubishi Tanabe Pharma Corporation (MTPC), has built a proud heritage of developing innovative pharmaceutical products.

The roots of our organization go back to 1678, when Tanabeya Gohei started a healthcare business called “Tanabeya Infusing Medicine.”

In the centuries since, a family of companies sharing a commitment to quality and innovation and to improving the lives of patients evolved into our parent corporation, now with a truly global focus.

Over our long history, our organization has provided quality pharmaceuticals to patients in Asia and Europe. Plus, our research laboratories have invented and licensed out products (such as diltiazem, fingolimod, canagliflozin, and more) to our partners, helping to improve the quality of life for patients throughout the world including the U.S.

For more information on our history, we invite you to visit the Mitsubishi Tanabe Pharma Historical Museum.

Now, our plan is to directly serve the patients of the United States, and we are grateful for the close ties that we have already formed with the U.S. healthcare community.

We look forward to a long, positive relationship.